Medicus Pharma CFO granted 1.47M shares, options
Medicus Pharma’s President and CFO received stock options and over 1.47 million common shares as equity compensation, increasing her direct holdings.
Rhea-AI Filing Summary
Medicus Pharma Ltd. (MDCX) reported that its President and CFO, Carolyn F. Bonner, received equity-based compensation on September 4, 2026. She was granted options to acquire 250,000 common shares at an exercise price of $0.1705 per share, vesting quarterly in four equal installments over one year and expiring on September 4, 2031. On the same date, she also acquired 1,470,588 common shares at $0.1705 per share, resulting in direct ownership of 1,489,493 common shares. No Rule 10b5-1 trading plan is reported for these awards.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Grant/Award: 1,720,588 shares
Grant/Award
2 txns
Insider
Bonner Carolyn F.
Role
President and CFO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) F1 | 250,000 | $0.00 | $0.00 |
| Grant/Award | Common Shares, no par value | 1,470,588 | $0.1705 | $251K |
Holdings After Transaction:
Stock Option (right to buy) — 250,000 contracts (Direct);
Common Shares, no par value — 1,489,493 shares (Direct)
Footnotes (1)
- F1. The option was granted on September 4, 2026. The option is scheduled to vest quarterly in four equal installments over one year.
Key Figures
Stock options granted: 250,000 options
Option exercise price: $0.1705 per share
Option expiration date: September 4, 2031
+3 more
6 metrics
Stock options granted
250,000 options
Options to buy common shares granted on September 4, 2026
Option exercise price
$0.1705 per share
Exercise price for 250,000 options granted to the President and CFO
Option expiration date
September 4, 2031
Expiration of options granted on September 4, 2026
Common shares granted
1,470,588 shares
Common shares acquired as an award on September 4, 2026
Share grant price
$0.1705 per share
Price per common share for the 1,470,588-share grant
Common shares held after grant
1,489,493 shares
Direct common share holdings of Carolyn F. Bonner after the transactions
Key Terms
stock option, vesting, exercise price, expiration date, +1 more
5 terms
stock option financial
"She was granted options to acquire 250,000 common shares at an exercise price"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vesting financial
"The option is scheduled to vest quarterly in four equal installments over one year"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"options to acquire 250,000 common shares at an exercise price of $0.1705 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiring on September 4, 2031"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
no par value financial
"1,470,588 common shares, no par value"
Shares described as "no par value" are equity securities issued without a fixed face amount written into the corporate charter; their legal capital is not tied to a specific per-share number and the company may record proceeds differently than for par-value shares. This matters to investors because it affects how a company records equity, sets minimum legal capital, and handles bookkeeping for issuances, dividends and splits—similar to buying slices of a pie where the slice has no printed sticker price and market forces determine worth.
FAQ
What equity awards did MDCX grant to its President and CFO on September 4, 2026?
Medicus Pharma granted Carolyn F. Bonner 250,000 stock options with an exercise price of $0.1705 per share and 1,470,588 common shares at $0.1705 per share as equity compensation.
How do the stock options for MDCX’s President and CFO vest?
The options granted to Carolyn F. Bonner are scheduled to vest quarterly in four equal installments over one year, according to the footnote describing the award terms.
What is the exercise price and expiration date of the MDCX options granted?
The options granted to Carolyn F. Bonner have an exercise price of $0.1705 per common share and are scheduled to expire on September 4, 2031, if not earlier exercised or forfeited.
Were the MDCX insider transactions under a Rule 10b5-1 trading plan?
No. The Form 4 indicates that no Rule 10b5-1 trading plan applies to these transactions, so they are not reported as pre-arranged trades under such a plan.
What type of securities did MDCX’s President and CFO receive in this Form 4?
Carolyn F. Bonner received stock options giving the right to buy common shares and a separate grant of 1,470,588 common shares, no par value, both reported as directly owned.
AI-generated analysis. How Rhea-AI works. Not financial advice.
